Meeting
2015 Gastrointestinal Cancers Symposium
Comparison between neoadjuvant chemotherapy followed by surgery (NAC-S) and definitive chemoradiotherapy (CRT) in overall survival for patients with clinical stage II-III esophageal squamous cell carcinoma (ESCC) (JCOG1406-A).
Authors
Motoo Nomura
Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan
Motoo Nomura , Ken Kato , Junki Mizusawa , Kozo Kataoka , Nobutoshi Ando , Kei Muro , Atsushi Ohtsu , Hiroyasu Igaki , Masayuki Shinoda , Hiroya Takeuchi , Hideaki Shimizu , Kazuhiko Hayashi , Hiroyuki Daiko , Masahiro Goto , Yoshito Komatsu , Kazuo Konishi , Yoshinori Miyata , Yuko Kitagawa
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session A: Cancers of the Esophagus and Stomach
Track
Cancers of the Esophagus and Stomach
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 33, 2015 (suppl 3; abstr 127)
DOI
10.1200/jco.2015.33.3_suppl.127
Abstract #
127
Poster Bd #
C25
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Safety and short-term efficacy of neoadjuvant FLOT therapy in patients with resectable esophageal squamous cell carcinoma.
First Author: Yuri Yoshinami
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Definitive chemoradiotherapy for locoregional recurrence of esophageal squamous cell carcinoma patients after radical surgery: Retrospective study.
First Author: Kentaro Harada
Poster
2019 Gastrointestinal Cancers Symposium
A retrospective analysis of neoadjuvant chemotherapy followed by surgery or definitive chemoradiotherapy in patients with advanced esophageal squamous cell carcinoma.
First Author: Hiroshi Nakatsumi
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Short-term safety of adjuvant nivolumab therapy after neoadjuvant docetaxel plus cisplatin and 5-FU therapy for locally advanced esophageal squamous cell carcinoma.
First Author: Toshiharu Hirose